Food and Drug Administration, HHS
The Food and Drug Administration is correcting a notice entitled “Data Integrity and Compliance With Drug CGMP: Questions and Answers; Guidance for Industry; Availability” that appeared in the Federal Register of December 13, 2018. The document announced the availability of a guidance for industry. The document was published with the incorrect docket number. This document corrects that error. Previously submitted comments will be transferred to the correct docket number.
Start Further Info
FOR FURTHER INFORMATION CONTACT:
Karen Takahashi, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 75, Rm. 6686, Start Printed Page 8876Silver Spring, MD 20993-0002, 301-796-3191.
End Further Info
Start Supplemental Information
In the Federal Register of Thursday, December 13, 2018 (83 FR 64132), in FR Doc. 2018-26957, the following correction is made:
On page 64132, in the first column, in the header of the document, “[Docket No. FDA-2018-D-3984]” is corrected to read “[Docket No. FDA-2016-D-1113].”
End Supplemental Information
Dated: March 6, 2019.
Lowell J. Schiller,
Acting Associate Commissioner for Policy.
[FR Doc. 2019-04431 Filed 3-11-19; 8:45 am]
BILLING CODE 4164-01-P